JPRN-jRCT2080221187未知2 期
Phase II Study of ME3738 in Chronic Hepatitis C Patients.
适应症
试验速览
- 阶段
- 2 期
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •IFN treatment-naive patients
排除标准
- •- Patients with chronic liver diseases except chronic hepatitis C, such as chronic hepatitis B, alcoholic hepatitis or autoimmune hepatitis.
- •- Patients with hepatic cirrhosis or hepatoma
研究者
相似试验
进行中（未招募）
不适用
Evaluation of chronic hepatitis C treatment with PEG-IFN ALFA-2a and ribavirin in HIV-positive subjects with persistently normal transaminase levels. - Treatment of co-infected patients with normal ALTTreatment of adult patients with hystologically demonstrated chronic C hepatitis without hepatic failure and HCV-RNA positive, treatment of patients with normal ALT and with HIV/HCV co-infection.MedDRA version: 9.1Level: LLTClassification code 10019744Term: Hepatitis CEUCTR2007-005698-76-ITAZIENDA OSPEDALIERA L. SACCO (A.O. DI RILIEVO NAZIONALE)
已完成
不适用
Study on chronic hepatitis C treatment with interferon alpha, ribavirin and amantadine in naive patients.Chronic viral hepatitisInfections and InfestationsHepatitis CISRCTN74271466niversity Medical Centre Utrecht (UMCU) (Netherlands)390
已完成
不适用
TREATMENT OF PATIENTS WITH CHRONIC HEPATITIS C (HCC) USING PEG-INTERFERON ALPHA 2B AND RIBAVIRINEPER-039-01SCHERING PLOUGH RESEARCH INSTITUTE,
已完成
不适用
Retreatment of chronic hepatitis C patients with pegylated interferon (IFN), ribavirin and amantadine; a pilot study to establish if initial drop in viral load is predictive for sustained virological responseHepatitis CISRCTN81536220Academic Medical Center (AMC), Department of Gastroenterology, AMC Liver Center (The Netherlands)100
已完成
2 期
Phase 2B Dose Ranging Study of Locteron Plus Ribavirin to Treat HCVHepatitis C, ChronicNCT00863239Biolex Therapeutics, Inc.116